Back to 
BlackRock Finance, Inc.
BlackRock Finance, Inc.
JSPR
2 quarters
Position history for BlackRock Finance, Inc.'s holdings in Jasper Therapeutics, Inc.
As of its last 13F, for Q2 2024, BlackRock Finance held 692,980 shares of JSPR (Jasper Therapeutics), worth $15.7M. It increased the position from 193,422 shares in Q1 2024. BlackRock Finance held JSPR from Q1 2024 to Q2 2024, across 2 quarterly 13F filings.
Current Value
$15.7M
Current Shares
692,980
Total Value Change
+$10.1M
Total Shares Change
+499,558
Quarter-by-Quarter History
Other major holders of JSPR: Carlyle Group Inc., Franklin Templeton Inc.